Arsenic Trioxide and Breast Cancer: Analysis of the Apoptotic, Differentiative and Immunomodulatory Effects

Author： Baj G.

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.73, Iss.1, 2002-05, pp. : 61-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiosensitizing effects of arsenic trioxide on MCF-7 human breast cancer cells exposed to 89strontium chloride

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1894-1902

Spandidos Publications

Access to resources Recommend Favorite

Arsenic trioxide: A new immunomodulatory agent in the management of multiple myeloma

By Hussein Mohamad

Medical Oncology, Vol. 18, Iss. 4, 2001-12 ,pp. : 239-242

Humana Press, Inc

Access to resources Recommend Favorite

Cotylenin A and arsenic trioxide cooperatively suppress cell proliferation and cell invasion activity in human breast cancer cells

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 841-848

Spandidos Publications

Access to resources Recommend Favorite

Inactivation of Akt by arsenic trioxide induces cell death via mitochondrial-mediated apoptotic signaling in SGC-7901 human gastric cancer cells

Oncology Reports, Vol. 31, Iss. 4, 2014-01 ,pp. : 1645-1652

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells

By Liu Yaohua

Journal of Neuro-Oncology, Vol. 104, Iss. 2, 2011-09 ,pp. : 449-458

Springer Publishing Company

Access to resources Recommend Favorite